APO Research
Talk to an analyst

APO RESEARCH · REPORT

Adjuvants

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Adjuvants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025196 pages

Choose your research edition.

Industry ResearchAdjuvants Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Adjuvants Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Adjuvants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Adjuvants Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Adjuvants Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Adjuvants market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Adjuvants include GSK, Croda, CSL Limited, Phibro Animal Health, SDA BIO, SEPPIC, SPI Pharma, Vertellus and Huanuotai Biological, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Adjuvants market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Adjuvants and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Adjuvants sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Adjuvants market size, projected growth trends, production technologies, key applications, and end-use industries.

Adjuvants Segment by Company

GSK

Croda

CSL Limited

Phibro Animal Health

SDA BIO

SEPPIC

SPI Pharma

Vertellus

Huanuotai Biological

Rico Bio

Sanofi

Escon

Zhifei Biological

Adjuvants Segment by Type

Emulsion Adjuvants

Mineral Adjuvants

Others

Adjuvants Segment by Application

Human Vaccine

Veterinary Vaccine

Adjuvants Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adjuvants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Adjuvants market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Adjuvants Industry Trends Table 2. Adjuvants Industry Drivers Table 3. Adjuvants Industry Opportunities and Challenges Table 4. Adjuvants Industry Restraints Table 5. Global Adjuvants Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Adjuvants Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Adjuvants Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Adjuvants Sales Market Share by Manufacturers Table 9. Global Adjuvants Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Adjuvants Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Adjuvants Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Adjuvants Manufacturers, Product Type & Application Table 13. Global Adjuvants Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Adjuvants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Emulsion Adjuvants Table 17. Major Manufacturers of Mineral Adjuvants Table 18. Major Manufacturers of Others Table 19. Global Adjuvants Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Adjuvants Sales by Type (2021-2026) & (Tons) Table 21. Global Adjuvants Sales by Type (2027-2032) & (Tons) Table 22. Global Adjuvants Sales Market Share by Type (2021-2026) Table 23. Global Adjuvants Sales Market Share by Type (2027-2032) Table 24. Global Adjuvants Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 25. Global Adjuvants Revenue by Type (2021-2026) & (Tons) Table 26. Global Adjuvants Revenue by Type (2027-2032) & (Tons) Table 27. Global Adjuvants Revenue Market Share by Type (2021-2026) Table 28. Global Adjuvants Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Human Vaccine Table 30. Major Manufacturers of Veterinary Vaccine Table 31. Global Adjuvants Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Adjuvants Sales by Application (2021-2026) & (Tons) Table 33. Global Adjuvants Sales by Application (2027-2032) & (Tons) Table 34. Global Adjuvants Sales Market Share by Application (2021-2026) Table 35. Global Adjuvants Sales Market Share by Application (2027-2032) Table 36. Global Adjuvants Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 37. Global Adjuvants Revenue by Application (2021-2026) & (Tons) Table 38. Global Adjuvants Revenue by Application (2027-2032) & (Tons) Table 39. Global Adjuvants Revenue Market Share by Application (2021-2026) Table 40. Global Adjuvants Revenue Market Share by Application (2027-2032) Table 41. Global Adjuvants Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 42. Global Adjuvants Sales by Region (2021-2026) & (Tons) Table 43. Global Adjuvants Sales Market Share by Region (2021-2026) Table 44. Global Adjuvants Sales Forecasted by Region (2027-2032) & (Tons) Table 45. Global Adjuvants Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Adjuvants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 47. North America Adjuvants Sales by Country (2021-2026) & (Tons) Table 48. North America Adjuvants Sales by Country (2027-2032) & (Tons) Table 49. Europe Adjuvants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 50. Europe Adjuvants Sales by Country (2021-2026) & (Tons) Table 51. Europe Adjuvants Sales by Country (2027-2032) & (Tons) Table 52. Asia Pacific Adjuvants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 53. Asia Pacific Adjuvants Sales by Country (2021-2026) & (Tons) Table 54. Asia Pacific Adjuvants Sales by Country (2027-2032) & (Tons) Table 55. South America, Middle East and Africa Adjuvants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. South America, Middle East and Africa Adjuvants Sales by Country (2021-2026) & (Tons) Table 57. South America, Middle East and Africa Adjuvants Sales by Country (2027-2032) & (Tons) Table 58. Global Adjuvants Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Adjuvants Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Adjuvants Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Adjuvants Revenue Market Share by Region (2021-2026) Table 62. Global Adjuvants Revenue Market Share by Region (2027-2032) Table 63. GSK Company Information Table 64. GSK Business Overview Table 65. GSK Adjuvants Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. GSK Adjuvants Product Portfolio Table 67. GSK Recent Development Table 68. Croda Company Information Table 69. Croda Business Overview Table 70. Croda Adjuvants Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Croda Adjuvants Product Portfolio Table 72. Croda Recent Development Table 73. CSL Limited Company Information Table 74. CSL Limited Business Overview Table 75. CSL Limited Adjuvants Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. CSL Limited Adjuvants Product Portfolio Table 77. CSL Limited Recent Development Table 78. Phibro Animal Health Company Information Table 79. Phibro Animal Health Business Overview Table 80. Phibro Animal Health Adjuvants Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Phibro Animal Health Adjuvants Product Portfolio Table 82. Phibro Animal Health Recent Development Table 83. SDA BIO Company Information Table 84. SDA BIO Business Overview Table 85. SDA BIO Adjuvants Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. SDA BIO Adjuvants Product Portfolio Table 87. SDA BIO Recent Development Table 88. SEPPIC Company Information Table 89. SEPPIC Business Overview Table 90. SEPPIC Adjuvants Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. SEPPIC Adjuvants Product Portfolio Table 92. SEPPIC Recent Development Table 93. SPI Pharma Company Information Table 94. SPI Pharma Business Overview Table 95. SPI Pharma Adjuvants Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. SPI Pharma Adjuvants Product Portfolio Table 97. SPI Pharma Recent Development Table 98. Vertellus Company Information Table 99. Vertellus Business Overview Table 100. Vertellus Adjuvants Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Vertellus Adjuvants Product Portfolio Table 102. Vertellus Recent Development Table 103. Huanuotai Biological Company Information Table 104. Huanuotai Biological Business Overview Table 105. Huanuotai Biological Adjuvants Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Huanuotai Biological Adjuvants Product Portfolio Table 107. Huanuotai Biological Recent Development Table 108. Rico Bio Company Information Table 109. Rico Bio Business Overview Table 110. Rico Bio Adjuvants Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Rico Bio Adjuvants Product Portfolio Table 112. Rico Bio Recent Development Table 113. Sanofi Company Information Table 114. Sanofi Business Overview Table 115. Sanofi Adjuvants Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Sanofi Adjuvants Product Portfolio Table 117. Sanofi Recent Development Table 118. Escon Company Information Table 119. Escon Business Overview Table 120. Escon Adjuvants Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Escon Adjuvants Product Portfolio Table 122. Escon Recent Development Table 123. Zhifei Biological Company Information Table 124. Zhifei Biological Business Overview Table 125. Zhifei Biological Adjuvants Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Zhifei Biological Adjuvants Product Portfolio Table 127. Zhifei Biological Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Adjuvants Distributors List Table 131. Adjuvants Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Adjuvants Product Image Figure 2. Global Adjuvants Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adjuvants Market Size (2021-2032) & (US$ Million) Figure 4. Global Adjuvants Sales (2021-2032) & (Tons) Figure 5. Global Adjuvants Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Adjuvants Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Emulsion Adjuvants Image Figure 9. Mineral Adjuvants Image Figure 10. Others Image Figure 11. Global Adjuvants Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Adjuvants Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Adjuvants Sales Market Share by Type (2021-2032) Figure 14. Global Adjuvants Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 15. Global Adjuvants Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Adjuvants Revenue Market Share by Type (2021-2032) Figure 17. Human Vaccine Image Figure 18. Veterinary Vaccine Image Figure 19. Global Adjuvants Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Adjuvants Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Adjuvants Sales Market Share by Application (2021-2032) Figure 22. Global Adjuvants Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Adjuvants Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Adjuvants Revenue Market Share by Application (2021-2032) Figure 25. North America Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 26. North America Adjuvants Sales Market Share by Country (2021-2032) Figure 27. U.S. Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 28. Canada Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 29. Mexico Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Europe Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 31. Europe Adjuvants Sales Market Share by Country (2021-2032) Figure 32. Germany Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 33. France Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 34. U.K. Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Italy Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Netherlands Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Asia Pacific Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 38. Asia Pacific Adjuvants Sales Market Share by Country (2021-2032) Figure 39. China Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 40. Japan Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 41. South Korea Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 42. Southeast Asia Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 43. India Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 44. Australia Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 45. South America, Middle East and Africa Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 46. South America, Middle East and Africa Adjuvants Sales Market Share by Country (2021-2032) Figure 47. Brazil Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 48. South Africa Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 49. Saudi Arabia Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Turkey Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 51. Argentina Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 52. UAE Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Egypt Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Chile Adjuvants Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Global Adjuvants Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Adjuvants Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Adjuvants Revenue (2021-2032) & (US$ Million) Figure 58. North America Adjuvants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Adjuvants Revenue (2021-2032) & (US$ Million) Figure 60. Europe Adjuvants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Adjuvants Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Adjuvants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Adjuvants Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Adjuvants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Adjuvants Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Adjuvants Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Emulsion Adjuvants
  • Mineral Adjuvants
  • Others
Applications
  • Human Vaccine
  • Veterinary Vaccine
Companies covered
  • GSK
  • Croda
  • CSL Limited
  • Phibro Animal Health
  • SDA BIO
  • SEPPIC
  • SPI Pharma
  • Vertellus
  • Huanuotai Biological
  • Rico Bio
  • Sanofi
  • Escon
  • Zhifei Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Adjuvants Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Adjuvants Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Adjuvants Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Adjuvants Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Adjuvants Market Dynamics
  1. 2.1 Adjuvants Industry Trends
  2. 2.2 Adjuvants Industry Drivers
  3. 2.3 Adjuvants Industry Opportunities and Challenges
  4. 2.4 Adjuvants Industry Restraints
3 Adjuvants Market by Manufacturers
  1. 3.1 Global Adjuvants Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Adjuvants Sales by Manufacturers (2021-2026)
  3. 3.3 Global Adjuvants Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Adjuvants Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Adjuvants Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Adjuvants Manufacturers, Product Type & Application
  7. 3.7 Global Adjuvants Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Adjuvants Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Adjuvants Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Adjuvants Tier 1, Tier 2, and Tier 3
4 Adjuvants Market by Type
  1. 4.1 Adjuvants Type Introduction
  2. 4.1.1 Emulsion Adjuvants
  3. 4.1.2 Mineral Adjuvants
  4. 4.1.3 Others
  5. 4.2 Global Adjuvants Sales by Type
  6. 4.2.1 Global Adjuvants Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Adjuvants Sales by Type (2021-2032)
  8. 4.2.3 Global Adjuvants Sales Market Share by Type (2021-2032)
  9. 4.3 Global Adjuvants Revenue by Type
  10. 4.3.1 Global Adjuvants Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Adjuvants Revenue by Type (2021-2032)
  12. 4.3.3 Global Adjuvants Revenue Market Share by Type (2021-2032)
5 Adjuvants Market by Application
  1. 5.1 Adjuvants Application Introduction
  2. 5.1.1 Human Vaccine
  3. 5.1.2 Veterinary Vaccine
  4. 5.2 Global Adjuvants Sales by Application
  5. 5.2.1 Global Adjuvants Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Adjuvants Sales by Application (2021-2032)
  7. 5.2.3 Global Adjuvants Sales Market Share by Application (2021-2032)
  8. 5.3 Global Adjuvants Revenue by Application
  9. 5.3.1 Global Adjuvants Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Adjuvants Revenue by Application (2021-2032)
  11. 5.3.3 Global Adjuvants Revenue Market Share by Application (2021-2032)
6 Global Adjuvants Sales by Region
  1. 6.1 Global Adjuvants Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Adjuvants Sales by Region (2021-2032)
  3. 6.2.1 Global Adjuvants Sales by Region (2021-2026)
  4. 6.2.2 Global Adjuvants Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Adjuvants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Adjuvants Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Adjuvants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Adjuvants Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Adjuvants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Adjuvants Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Adjuvants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Adjuvants Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Adjuvants Revenue by Region
  1. 7.1 Global Adjuvants Revenue by Region
  2. 7.1.1 Global Adjuvants Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Adjuvants Revenue by Region (2021-2026)
  4. 7.1.3 Global Adjuvants Revenue by Region (2027-2032)
  5. 7.1.4 Global Adjuvants Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Adjuvants Revenue (2021-2032)
  8. 7.2.2 North America Adjuvants Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Adjuvants Revenue (2021-2032)
  11. 7.3.2 Europe Adjuvants Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Adjuvants Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Adjuvants Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Adjuvants Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Adjuvants Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Adjuvants Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Adjuvants Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Croda
  8. 8.2.1 Croda Company Information
  9. 8.2.2 Croda Business Overview
  10. 8.2.3 Croda Adjuvants Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Croda Adjuvants Product Portfolio
  12. 8.2.5 Croda Recent Developments
  13. 8.3 CSL Limited
  14. 8.3.1 CSL Limited Company Information
  15. 8.3.2 CSL Limited Business Overview
  16. 8.3.3 CSL Limited Adjuvants Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CSL Limited Adjuvants Product Portfolio
  18. 8.3.5 CSL Limited Recent Developments
  19. 8.4 Phibro Animal Health
  20. 8.4.1 Phibro Animal Health Company Information
  21. 8.4.2 Phibro Animal Health Business Overview
  22. 8.4.3 Phibro Animal Health Adjuvants Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Phibro Animal Health Adjuvants Product Portfolio
  24. 8.4.5 Phibro Animal Health Recent Developments
  25. 8.5 SDA BIO
  26. 8.5.1 SDA BIO Company Information
  27. 8.5.2 SDA BIO Business Overview
  28. 8.5.3 SDA BIO Adjuvants Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 SDA BIO Adjuvants Product Portfolio
  30. 8.5.5 SDA BIO Recent Developments
  31. 8.6 SEPPIC
  32. 8.6.1 SEPPIC Company Information
  33. 8.6.2 SEPPIC Business Overview
  34. 8.6.3 SEPPIC Adjuvants Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SEPPIC Adjuvants Product Portfolio
  36. 8.6.5 SEPPIC Recent Developments
  37. 8.7 SPI Pharma
  38. 8.7.1 SPI Pharma Company Information
  39. 8.7.2 SPI Pharma Business Overview
  40. 8.7.3 SPI Pharma Adjuvants Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SPI Pharma Adjuvants Product Portfolio
  42. 8.7.5 SPI Pharma Recent Developments
  43. 8.8 Vertellus
  44. 8.8.1 Vertellus Company Information
  45. 8.8.2 Vertellus Business Overview
  46. 8.8.3 Vertellus Adjuvants Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vertellus Adjuvants Product Portfolio
  48. 8.8.5 Vertellus Recent Developments
  49. 8.9 Huanuotai Biological
  50. 8.9.1 Huanuotai Biological Company Information
  51. 8.9.2 Huanuotai Biological Business Overview
  52. 8.9.3 Huanuotai Biological Adjuvants Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Huanuotai Biological Adjuvants Product Portfolio
  54. 8.9.5 Huanuotai Biological Recent Developments
  55. 8.10 Rico Bio
  56. 8.10.1 Rico Bio Company Information
  57. 8.10.2 Rico Bio Business Overview
  58. 8.10.3 Rico Bio Adjuvants Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Rico Bio Adjuvants Product Portfolio
  60. 8.10.5 Rico Bio Recent Developments
  61. 8.11 Sanofi
  62. 8.11.1 Sanofi Company Information
  63. 8.11.2 Sanofi Business Overview
  64. 8.11.3 Sanofi Adjuvants Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sanofi Adjuvants Product Portfolio
  66. 8.11.5 Sanofi Recent Developments
  67. 8.12 Escon
  68. 8.12.1 Escon Company Information
  69. 8.12.2 Escon Business Overview
  70. 8.12.3 Escon Adjuvants Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Escon Adjuvants Product Portfolio
  72. 8.12.5 Escon Recent Developments
  73. 8.13 Zhifei Biological
  74. 8.13.1 Zhifei Biological Company Information
  75. 8.13.2 Zhifei Biological Business Overview
  76. 8.13.3 Zhifei Biological Adjuvants Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Zhifei Biological Adjuvants Product Portfolio
  78. 8.13.5 Zhifei Biological Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Adjuvants Value Chain Analysis
  2. 9.1.1 Adjuvants Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Adjuvants Production Mode & Process
  6. 9.2 Adjuvants Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Adjuvants Distributors
  9. 9.2.3 Adjuvants Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst